(amivantamab + hyaluronidase (human recombinant))
Marketedupdated 2mo agoby $JNJ JOHNSON & JOHNSON
Approvedcommunity read0 votes
indications
investigational
NSCLC
all catalysts(2)
approval · 2
News(0)
no news has mentioned this drug yet
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that